JENNIFER BACHER: Open Payments
NPI 1831730878 · HAGERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,434 in 69 payments from 16 companies in 2025. Trend: 2023 $1,260 · 2024 $1,590 · 2025 $1,434
Food & beverage: $1,325Education: $109
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $399 |
| ABBVIE INC. | 11 | $210 |
| Novartis Pharmaceuticals Corporation | 7 | $183 |
| UCB, Inc. | 3 | $117 |
| Regeneron Healthcare Solutions, Inc. | 4 | $102 |
| Lilly USA, LLC | 4 | $96 |
| PFIZER INC. | 3 | $57 |
| Galderma Laboratories, L.P. | 3 | $51 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $47 |
| Arcutis Biotherapeutics, Inc. | 2 | $43 |
Products named: TREMFYA, SKYRIZI, COSENTYX, Bimzelx, DUPIXENT, Rhapsido, CIBINQO, EBGLYSS.
Industry payments across MD — which companies pay providers there.
